| 1 |
Mast MP, Mesquita L, Gan K, Gelperina S, das Neves J, Wacker MG. Encapsulation and release of hydrocortisone from proliposomes govern vaginal delivery. Drug Deliv Transl Res 2023;13:1022-34. [PMID: 36585558 DOI: 10.1007/s13346-022-01263-x] [Reference Citation Analysis]
|
| 2 |
Sapienza Passos J, Dartora VFMC, Cassone Salata G, Draszesski Malagó I, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. Int J Pharm 2023;635:122681. [PMID: 36738808 DOI: 10.1016/j.ijpharm.2023.122681] [Reference Citation Analysis]
|
| 3 |
Diep E, Schiffman JD. Electrospinning Living Bacteria: A Review of Applications from Agriculture to Health Care. ACS Appl Bio Mater 2023;6:951-64. [PMID: 36791266 DOI: 10.1021/acsabm.2c01055] [Reference Citation Analysis]
|
| 4 |
Abidin IZ, Murphy EJ, Fehrenbach GW, Rezoagli E, Gately N, Major I. A systematic review of mucoadhesive vaginal tablet testing. Drug Target Insights 2023;17:5-30. [PMID: 36687797 DOI: 10.33393/dti.2023.2477] [Reference Citation Analysis]
|
| 5 |
Agrahari V, Anderson SM, Peet MM, Wong AP, Singh ON, Doncel GF, Clark MR. Long-acting HIV Pre-exposure Prophylaxis (PrEP) approaches: Recent advances, emerging technologies and development challenges. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2135699] [Reference Citation Analysis]
|
| 6 |
Szymańska E, Wojasiński M, Dąbrowska J, Krzyżowska M, Nowicka M, Ciach T, Winnicka K. Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate - The effect of vaginal pH on drug carrier performance. Int J Biol Macromol 2022:S0141-8130(22)02146-8. [PMID: 36174868 DOI: 10.1016/j.ijbiomac.2022.09.207] [Reference Citation Analysis]
|
| 7 |
Franco-de la Torre L, Gómez-Sánchez E, Serafín-Higuera NA, Alonso-Castro ÁJ, López-Verdín S, Molina-Frechero N, Granados-Soto V, Isiordia-Espinoza MA. Dexamethasone Increases the Anesthetic Success in Patients with Symptomatic Irreversible Pulpitis: A Meta-Analysis. Pharmaceuticals (Basel) 2022;15. [PMID: 35890176 DOI: 10.3390/ph15070878] [Reference Citation Analysis]
|
| 8 |
Hsu CC, Hsu I, Lee LH, Hsu R, Hsueh YS, Lin CY, Chang HH. Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women. Pharmaceutics 2022;14:869. [PMID: 35456706 DOI: 10.3390/pharmaceutics14040869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Palmeira-de-Oliveira R, Oliveira AS, Rolo J, Tomás M, Palmeira-de-Oliveira A, Simões S, Martinez-de-Oliveira J. Women's preferences and acceptance for different drug delivery routes and products. Adv Drug Deliv Rev 2022;182:114133. [PMID: 35104506 DOI: 10.1016/j.addr.2022.114133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]
|
| 11 |
Thapa R, Gurung S, Parat M, Parekh HS, Pandey P. Application of Sol–Gels for Treatment of Gynaecological Conditions—Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery. Gels 2022;8:99. [DOI: 10.3390/gels8020099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
